BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9139240)

  • 1. Metrifonate and dichlorvos: effects of a single oral administration on cholinesterase activity in rat brain and blood.
    Hinz V; Grewig S; Schmidt BH
    Neurochem Res; 1996 Mar; 21(3):339-45. PubMed ID: 9139240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metrifonate induces cholinesterase inhibition exclusively via slow release of dichlorvos.
    Hinz VC; Grewig S; Schmidt BH
    Neurochem Res; 1996 Mar; 21(3):331-7. PubMed ID: 9139239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of subchronic administration of metrifonate on cholinergic neurotransmission in rats.
    Hinz VC; Kolb J; Schmidt BH
    Neurochem Res; 1998 Jul; 23(7):931-8. PubMed ID: 9690734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats.
    van der Staay FJ; Hinz VC; Schmidt BH
    J Pharmacol Exp Ther; 1996 Aug; 278(2):697-708. PubMed ID: 8768721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain.
    Soininen H; Unni L; Shillcutt S
    Neurochem Res; 1990 Dec; 15(12):1185-90. PubMed ID: 1711162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal patch delivery of acetylcholinesterase inhibitors.
    Moriearty PL; Thornton SL; Becker RE
    Methods Find Exp Clin Pharmacol; 1993; 15(6):407-12. PubMed ID: 8231460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by metrifonate and dichlorvos of cholinesterases in schistosomes.
    Bueding E; Liu CL; Rogers SH
    Br J Pharmacol; 1972 Nov; 46(3):480-7. PubMed ID: 4656609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of metrifonate in humans.
    Unni LK; Womack C; Hannant ME; Becker RE
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):285-9. PubMed ID: 8051989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic metrifonate treatment on cholinergic enzymes and the blood-brain barrier.
    Rakonczay Z; Papp H
    Neurochem Int; 2001 Jul; 39(1):19-24. PubMed ID: 11311445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metrifonate treatment enhances acquisition of eyeblink conditioning in aging rabbits.
    Kronforst-Collins MA; Moriearty PL; Ralph M; Becker RE; Schmidt B; Thompson LT; Disterhoft JF
    Pharmacol Biochem Behav; 1997 Jan; 56(1):103-10. PubMed ID: 8981616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of brain cholinesterase inhibition following metrifonate administration.
    Dachir S; Schmidt BH; Levy A
    Neurochem Res; 1999 Aug; 24(8):1075-80. PubMed ID: 10478948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of metrifonate and dichlorvos in plasma and erythrocytes during treatment of schistosomiasis with Bilarcil.
    Nordgren I; Bengtsson E; Holmstedt B; Pettersson BM
    Acta Pharmacol Toxicol (Copenh); 1981; 49 Suppl 5():79-86. PubMed ID: 7344416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of subchronic metrifonate treatment on cerebral glucose metabolism in young and aged rats.
    Poindessous-Jazat F; Schmidt BH; Bassant MH
    Eur J Pharmacol; 1998 Dec; 363(1):17-28. PubMed ID: 9877077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats.
    Scali C; Casamenti F; Bellucci A; Costagli C; Schmidt B; Pepeu G
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):1067-80. PubMed ID: 12111444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of metrifonate and dichlorvos in blood and tissues by gas chromatography-mass spectrometry.
    Nordgren I
    Fundam Appl Toxicol; 1981; 1(2):230-7. PubMed ID: 7184787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats.
    Scali C; Giovannini MG; Bartolini L; Prosperi C; Hinz V; Schmidt B; Pepeu G
    Eur J Pharmacol; 1997 May; 325(2-3):173-80. PubMed ID: 9163564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of food and time of administration on the pharmacokinetic and pharmacodynamic profile of metrifonate.
    Heinig R; Sachse R
    Int J Clin Pharmacol Ther; 1999 Sep; 37(9):456-64. PubMed ID: 10507245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of subchronic treatment with metrifonate and tacrine on brain cholinergic function in aged F344 rats.
    Giovannini MG; Scali C; Bartolini L; Schmidt B; Pepeu G
    Eur J Pharmacol; 1998 Jul; 354(1):17-24. PubMed ID: 9726626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor metrifonate in patients with renal impairment.
    Dingemanse J; Halabi A; Kleinbloesem CH; Heinig R; Blume H
    Ther Drug Monit; 1999 Jun; 21(3):310-6. PubMed ID: 10365643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metrifonate in healthy volunteers: interrelationship between pharmacokinetic properties, cholinesterase inhibition and side-effects.
    Aden-Abdi Y; Villén T; Ericsson O; Gustafsson LL; Dahl-Puustinen ML
    Bull World Health Organ; 1990; 68(6):731-6. PubMed ID: 2073711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.